Status:
UNKNOWN
Long-Term Functional, Quality-of-Life, Neuropsychological and Cognitive Outcomes in COVID-19 Critical Illness Survivors
Lead Sponsor:
University of Zurich
Conditions:
Covid19
ARDS
Eligibility:
All Genders
18+ years
Brief Summary
The corona virus disease 2019 (COVID-19), suddenly incepted in December 2019 in Wuhan, China, leading to one of the greatest health care emergencies of the last century. Acute exacerbation of the COVI...
Detailed Description
Health-care systems are ever improving, organ-support is advancing towards un-thought of possibilities and critical care medicine is becoming a field of evidence. As a consequence critical illness is ...
Eligibility Criteria
Inclusion
- Previous admission to one of the participating centers for COVID-19 critical illness treatment
- Previously proven SARS-CoV-2 infection
- Critical COVID-19 defined as respiratory failure and/ or shock and/ or multiorgan dysfunction or failure
- Signed Study Informed Consent
Exclusion
- Age \<18 years
- Rejection of the study
Key Trial Info
Start Date :
May 7 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04881266
Start Date
May 7 2021
End Date
December 31 2023
Last Update
May 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Zurich
Zurich, Switzerland, 8091